Milestone Pharmaceuticals (MIST) Tax Provisions (2018 - 2020)
Milestone Pharmaceuticals' (MIST) quarterly Tax Provisions came in at -$17000.0 in Q3 2020, up 76.71% YoY from -$9620.2 in Q4 2019, and down 1600.0% on a QoQ basis from -$1000.0 in Q4 2019.
Milestone Pharmaceuticals (MIST) Tax Provisions (2018 - 2020) Analysis & Trends
Milestone Pharmaceuticals (MIST) has 3 years of Tax Provisions data on file, last reported at -$17000.0 in Q3 2020.
- Quarterly Tax Provisions rose 76.71% year-over-year to -$17000.0 in Q3 2020, while the trailing twelve-month figure through Dec 2020 was -$91000.0 (down 62.5% YoY) and the FY2020 annual result came in at -$17000.0, up 69.64% from the prior year.
- Tax Provisions slipped to -$17000.0 in Q3 2020, from -$1000.0 in the prior quarter.
- In the past five years, Tax Provisions ranged from a high of $56000.0 in Q4 2018 to a low of -$73000.0 in Q3 2019.
- A 3-year average of $125.0 and a median of $500.0 in 2018 frame the typical range for Tax Provisions.
- Annual changes were most pronounced in 2019 — Tax Provisions sank 300.0% — and 2020, when it surged 76.71%.
- Tracing MIST's Tax Provisions over 3 years: stood at $56000.0 in 2018, then plunged by 101.79% to -$1000.0 in 2019, then sank by 1600.0% to -$17000.0 in 2020.
- The last three Tax Provisions figures came in at -$17000.0 (Q3 2020), -$1000.0 (Q4 2019), and -$73000.0 (Q3 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.92 Bn | 131.07 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.91 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 64.87 Bn | 59.68 Bn | 1.37 Bn | 59.00 Mn |
| 4 | Moderna | 58.18 Bn | 53.04 Bn | 52.00 Mn | 15.00 Mn |
| 5 | BeOne Medicines | 41.96 Bn | 36.87 Bn | 1.53 Bn | 75.45 Mn |
| 6 | Alnylam Pharmaceuticals | 31.53 Bn | 28.23 Bn | 992.69 Mn | 13.31 Mn |
| 7 | BioNTech SE | 27.79 Bn | 9.40 Bn | 668.28 Mn | -90.33 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn | 1.90 Mn |
| 9 | Royalty Pharma | 27.37 Bn | 26.53 Bn | - | - |
| 10 | Milestone Pharmaceuticals | 43.32 Mn | -128.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2020 | -17,000.00 |
| Dec 31, 2019 | -1,000.00 |
| Sep 30, 2019 | -73,000.00 |
| Jun 30, 2019 | -4,000.00 |
| Mar 31, 2019 | 22,000.00 |
| Dec 31, 2018 | 56,000.00 |
| Jun 30, 2018 | 2,000.00 |
| Mar 31, 2018 | 16,000.00 |